KONINKLIJKE PHILIPS NV (PHI1.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:PHI1 - NL0000009538 - Common Stock
24.74 EUR
+0.13 (+0.53%)
PHI1 gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 63 industry peers in the Health Care Equipment & Supplies industry. PHI1 has a bad profitability rating. Also its financial health evaluation is rather negative. PHI1 has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
- In the past year PHI1 was profitable.
- PHI1 had a positive operating cash flow in the past year.
- In multiple years PHI1 reported negative net income over the last 5 years.
- Of the past 5 years PHI1 4 years had a positive operating cash flow.
1.2 Ratios
- PHI1's Return On Assets of 0.63% is on the low side compared to the rest of the industry. PHI1 is outperformed by 60.32% of its industry peers.
- PHI1 has a Return On Equity of 1.56%. This is in the lower half of the industry: PHI1 underperforms 60.32% of its industry peers.
- PHI1 has a worse Return On Invested Capital (3.95%) than 60.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.63% | ||
| ROE | 1.56% | ||
| ROIC | 3.95% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With a Profit Margin value of 0.93%, PHI1 is not doing good in the industry: 60.32% of the companies in the same industry are doing better.
- The Operating Margin of PHI1 (6.10%) is comparable to the rest of the industry.
- PHI1's Operating Margin has declined in the last couple of years.
- With a Gross Margin value of 43.49%, PHI1 is not doing good in the industry: 76.19% of the companies in the same industry are doing better.
- PHI1's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.1% | ||
| PM (TTM) | 0.93% | ||
| GM | 43.49% |
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), PHI1 is destroying value.
- Compared to 1 year ago, PHI1 has less shares outstanding
- The number of shares outstanding for PHI1 has been increased compared to 5 years ago.
- PHI1 has a worse debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 1.99 indicates that PHI1 is not a great score, but indicates only limited risk for bankruptcy at the moment.
- With a Altman-Z score value of 1.99, PHI1 is not doing good in the industry: 60.32% of the companies in the same industry are doing better.
- PHI1 has a debt to FCF ratio of 14.51. This is a negative value and a sign of low solvency as PHI1 would need 14.51 years to pay back of all of its debts.
- The Debt to FCF ratio of PHI1 (14.51) is worse than 60.32% of its industry peers.
- PHI1 has a Debt/Equity ratio of 0.69. This is a neutral value indicating PHI1 is somewhat dependend on debt financing.
- PHI1 has a Debt to Equity ratio of 0.69. This is in the lower half of the industry: PHI1 underperforms 73.02% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.69 | ||
| Debt/FCF | 14.51 | ||
| Altman-Z | 1.99 |
ROIC/WACC0.6
WACC6.59%
2.3 Liquidity
- PHI1 has a Current Ratio of 1.32. This is a normal value and indicates that PHI1 is financially healthy and should not expect problems in meeting its short term obligations.
- PHI1's Current ratio of 1.32 is in line compared to the rest of the industry. PHI1 outperforms 41.27% of its industry peers.
- A Quick Ratio of 0.86 indicates that PHI1 may have some problems paying its short term obligations.
- PHI1 has a Quick ratio of 0.86. This is in the lower half of the industry: PHI1 underperforms 65.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.32 | ||
| Quick Ratio | 0.86 |
3. Growth
3.1 Past
- PHI1 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.15%, which is quite good.
- The Earnings Per Share has been decreasing by -7.17% on average over the past years.
- PHI1 shows a decrease in Revenue. In the last year, the revenue decreased by -1.43%.
- Measured over the past years, PHI1 shows a small growth in Revenue. The Revenue has been growing by 1.00% on average per year.
EPS 1Y (TTM)15.15%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-1.43%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-1.71%
3.2 Future
- Based on estimates for the next years, PHI1 will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.28% on average per year.
- The Revenue is expected to grow by 3.00% on average over the next years.
EPS Next Y4.94%
EPS Next 2Y4.81%
EPS Next 3Y7.44%
EPS Next 5Y10.28%
Revenue Next Year-2.27%
Revenue Next 2Y0.25%
Revenue Next 3Y1.58%
Revenue Next 5Y3%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 16.72 indicates a correct valuation of PHI1.
- Compared to the rest of the industry, the Price/Earnings ratio of PHI1 indicates a rather cheap valuation: PHI1 is cheaper than 95.24% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 27.25, PHI1 is valued a bit cheaper.
- PHI1 is valuated correctly with a Price/Forward Earnings ratio of 16.26.
- 76.19% of the companies in the same industry are more expensive than PHI1, based on the Price/Forward Earnings ratio.
- Compared to an average S&P500 Price/Forward Earnings ratio of 25.98, PHI1 is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.72 | ||
| Fwd PE | 16.26 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, PHI1 is valued a bit cheaper than 71.43% of the companies in the same industry.
- PHI1's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 41.22 | ||
| EV/EBITDA | 13.02 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)3.38
PEG (5Y)N/A
EPS Next 2Y4.81%
EPS Next 3Y7.44%
5. Dividend
5.1 Amount
- No dividends for PHI1!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
KONINKLIJKE PHILIPS NV / PHI1.DE FAQ
What is the ChartMill fundamental rating of KONINKLIJKE PHILIPS NV (PHI1.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to PHI1.DE.
What is the valuation status for PHI1 stock?
ChartMill assigns a valuation rating of 4 / 10 to KONINKLIJKE PHILIPS NV (PHI1.DE). This can be considered as Fairly Valued.
How profitable is KONINKLIJKE PHILIPS NV (PHI1.DE) stock?
KONINKLIJKE PHILIPS NV (PHI1.DE) has a profitability rating of 2 / 10.
How financially healthy is KONINKLIJKE PHILIPS NV?
The financial health rating of KONINKLIJKE PHILIPS NV (PHI1.DE) is 2 / 10.
Can you provide the dividend sustainability for PHI1 stock?
The dividend rating of KONINKLIJKE PHILIPS NV (PHI1.DE) is 0 / 10 and the dividend payout ratio is 199.39%.